Gennao Bio

A genetic medicines company developing first-in-class, targeted nucleic acid therapeutics

General Information
Company Name
Gennao Bio
Founded Year
2020
Location (Offices)
Hopewell, United States +1
Founders / Decision Makers
Number of Employees
28
Industries
Biotechnology, Health Care, Life Sciences
Funding Stage
Series A
Social Media

Gennao Bio - Company Profile

Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology. GMAB is an adaptive technology that uses a novel, cell-penetrating antibody to non-covalently bind to and systemically deliver therapeutic levels of a wide variety of nucleic acid payloads to select cells, including mRNA, synthetic RNA, DNA, si-RNA, ASOs and gene-editing molecules. This non-viral delivery platform is differentiated from traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and employs well-established manufacturing processes. Gennao Bio is developing this delivery system with an initial focus on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases.

Funding Rounds & Investors of Gennao Bio (0)

View All

There is no investment information

Latest News of Gennao Bio

View All

No recent news or press coverage available for Gennao Bio.

Similar Companies to Gennao Bio

View All
PURMX Therapeutics,Inc. - Similar company to Gennao Bio
PURMX Therapeutics,Inc. Information service targetting pharma and bio.
Autotelic Bio Inc. - Similar company to Gennao Bio
Autotelic Bio Inc. RNA Therapeutics New Drug Development Company
GenoSmart - Similar company to Gennao Bio
GenoSmart Developing next gen medical devices
NanoGenics - Similar company to Gennao Bio
NanoGenics Making the promise of gene therapy a reality
Orion Therapeutics, Inc. - Similar company to Gennao Bio
Orion Therapeutics, Inc. Platform technology providing targeted delivery of RNA aimed at curing and preventing previously undruggable disease.